BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,000,000 Value ($000) $5,626 Avg Close — Range —
Q3 2025
Shares 5,000,000 Value ($000) $4,942 Avg Close — Range —
Q2 2025
Shares 10,000,000 Value ($000) $9,380 Avg Close — Range —
Q1 2025
Shares 10,000,000 Value ($000) $8,988 Avg Close — Range —
Q4 2024
Shares 10,000,000 Value ($000) $8,567 Avg Close — Range —
Q3 2024
Shares 10,000,000 Value ($000) $8,361 Avg Close — Range —
Q2 2024
Shares 10,000,000 Value ($000) $8,074 Avg Close — Range —
Q1 2024
Shares 10,000,000 Value ($000) $8,239 Avg Close — Range —
Q4 2023
Shares 10,000,000 Value ($000) $8,489 Avg Close — Range —
Q3 2023
Shares 10,000,000 Value ($000) $7,606 Avg Close — Range —
Q2 2023
Shares 10,000,000 Value ($000) $6,163 Avg Close — Range —
Q1 2023
Shares 10,000,000 Value ($000) $6,392 Avg Close — Range —
Q4 2022
Shares 10,000,000 Value ($000) $3,878 Avg Close — Range —
Q3 2022
Shares 10,000,000 Value ($000) $4,422 Avg Close — Range —
Q2 2022
Shares 10,000,000 Value ($000) $4,472 Avg Close — Range —
Q1 2022
Shares 10,000,000 Value ($000) $4,826 Avg Close — Range —